AMY HUNT: Open Payments
NPI 1093114076 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 33 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $437 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $198 |
| Novocure Inc. | 1 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Novo Nordisk Inc | 3 | $50 |
| Eisai Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| PFIZER INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Optune Lua (NovoTTF-200T), CAPLYTA, VRAYLAR, UBRELVY, QULIPTA, FARXIGA, Leqembi, Ozempic.
Industry payments across KS — which companies pay providers there.
